1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,106 | 0,134 | 22:25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Circio Holding ASA Key information related to the rights issue | 3 | Oslo Børs | ||
| Mo | Circio Holding ASA: Circio announces 88% underwritten and presubscribed NOK 50 million rights issue with strong support from existing shareholders | 2 | Oslo Børs | ||
| 03.12. | Circio Holding ASA: Corr*: Atlas Holdings for CIRCIO | 2 | Oslo Børs | ||
| 03.12. | Circio Holding ASA: Atlas Holdings for CIRCIO | 8 | Oslo Børs | ||
| 24.11. | Circio Holding ASA: Circio presents data that further strengthens and broadens its circVec circular RNA expression platform | 2 | Oslo Børs | ||
| CIRCIO Aktie jetzt für 0€ handeln | |||||
| 19.11. | Circio Holding ASA: Atlas Holdings for CIRCIO | - | Oslo Børs | ||
| 19.11. | Circio Holding ASA: Shareholding Disclosure - Nordnet | 1 | Oslo Børs | ||
| 18.11. | Circio Holding ASA: Shareholding disclosure - Nordnet AB | 1 | Oslo Børs | ||
| 17.11. | Circio Holding ASA: Circio issues invitation to R&D and corporate update webcast on 24 November 2025 | 2 | Oslo Børs | ||
| 30.10. | Circio Holding ASA: Corr: Atlas Holdings for CIRCIO | 9 | Oslo Børs | ||
| 30.10. | Circio Holding ASA: Atlas Holdings for CIRCIO | 1 | Oslo Børs | ||
| 20.10. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 1 | Oslo Børs | ||
| 15.10. | Circio Holding ASA: Requested Conversion of Convertible Bonds | 2 | Oslo Børs | ||
| 08.10. | Circio Holding ASA: Circio presents comprehensive circVec in vivo data package demonstrating 40-fold improvement over conventional AAV gene delivery at ESGCT 2025 | 3 | Oslo Børs | ||
| 06.10. | Circio Holding ASA: Requested Conversion of Convertible Bonds | 4 | Oslo Børs | ||
| 01.10. | Circio Holding ASA Approval and publication of prospectus for potential future share issues and conversion of convertible bonds | 3 | Oslo Børs | ||
| 01.10. | Circio Holding ASA: Circio to present comprehensive circVec-AAV in vivo data package at ESGCT 2025 | 9 | Oslo Børs | ||
| 09.09. | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 2 | Oslo Børs | ||
| 05.09. | Circio Holding ASA - Conversion of Convertible Bonds and funding requested under Additional Financing Commitment from Atlas | 1 | Oslo Børs | ||
| 28.08. | Circio 1H 2025 presentation: circVec technology shows 10-40x advantage in gene therapy | 3 | Investing.com |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 5,240 | -0,04 % | DAX-Check LIVE: Aurubis, Evotec, Formycon, Infineon, Porsche SE, Siemens Energy im Fokus | Die Erholung an der Börse hat sich zur Wochenmitte nicht fortgesetzt. Der DAX startete zwar mit kleinen Gewinnen in den Tag, rutschte im Verlauf jedoch ins Minus und schloss schließlich bei 23.694 Punkten... ► Artikel lesen | |
| MEDIGENE | 0,025 | -16,67 % | MEDIGENE AG zündet Kursrakete - ich sehe erst den Anfang! | ||
| VALNEVA | 3,826 | -0,57 % | Rheinmetall Aktie: Heiß! - Dt. Börse, Heidelberger Druck, Mutares, Steyr und Valneva im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| NOVAVAX | 5,654 | -1,84 % | Novavax, Inc. (NVAX): A Bull Case Theory | ||
| INOVIO PHARMACEUTICALS | 1,800 | -3,23 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review
Expect... ► Artikel lesen | |
| INFLARX | 0,880 | -2,44 % | InflaRx N.V.: InflaRx Announces International Nonproprietary Name of "Izicopan" for INF904 | JENA, Germany, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced... ► Artikel lesen | |
| BAVARIAN NORDIC | 25,250 | -0,28 % | Bavarian Nordic A/S: Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million | COPENHAGEN, Denmark, December 2, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12... ► Artikel lesen | |
| VAXART | 0,282 | +0,64 % | Vaxart, Inc.: Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results | Entered into an exclusive license agreement with Dynavax for the Company's COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed enrollment... ► Artikel lesen | |
| REDHILL BIOPHARMA | 1,200 | -4,00 % | RedHill Biopharma Ltd.: RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement | TEL-AVIV, Israel and RALEIGH, N.C., Dec. 1, 2025 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical... ► Artikel lesen | |
| EMERGENT BIOSOLUTIONS | 9,826 | -0,49 % | Emergent BioSolutions Reports Third Quarter 2025 Financial Results | Third Quarter 2025 Total Revenues of $231.1 million, above the high end of Q3 guidance by $21.0 millionThird Quarter 2025 Net Income of $51.2 million and Net Income Margin of 22%Third Quarter 2025... ► Artikel lesen | |
| TELIX PHARMACEUTICALS | 7,852 | -4,55 % | Telix Pharmaceuticals, Varian Team Up To Develop New Theranostic EBRT Applications | CANBERA (dpa-AFX) - Telix Pharmaceuticals Limited (TLX) on Wednesday announced collaboration with Varian, a Siemens Healthineers company, to develop new clinical applications that integrate... ► Artikel lesen | |
| SINOVAC BIOTECH | - | - | Sinovac Biotech Ltd. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal | BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received... ► Artikel lesen | |
| CYTOMX THERAPEUTICS | 3,488 | +4,43 % | CytomX Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of key data | ||
| AGENUS | 3,340 | -5,11 % | Agenus Inc.: Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances | France grants reimbursed access with patients having commenced treatment Two-year BOT/BAL survival presented at ESMO spanning more than five cancers in over 400 patients Phase 3 on... ► Artikel lesen | |
| NORTHWEST BIOTHERAPEUTICS | 0,184 | -2,13 % | Northwest Biotherapeutics, Inc.: Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility | BETHESDA, Md., Nov. 20, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax personalized immune therapies... ► Artikel lesen |
CIRCIO HOLDING ASA gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,107 Euro und damit -4,11 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIRCIO HOLDING ASA finden Sie auf Wallstreet Online.